Castle Biosciences Inc. (CSTL) Misses Q1 EPS by 26c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Join SI Premium – FREE
Castle Biosciences Inc. (NASDAQ: CSTL) reported Q1 EPS of ($1.10), $0.26 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $42.04 million versus the consensus estimate of $37.45 million.
For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GM to offer hybrid versions of top-selling SUV models - report
- Analyst explains why optical stocks are moving higher
- Eagle Bancorp Montana (EBMT) Misses Q3 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
